Biotech Values

[DewDiligence]

ALNY’s ALN-CC5 has a lot of pricing headroom, thanks to Soliris:

http://www.bloomberg.com/news/articles/2015-12-10/alnylam-going-after-world-s-most-expensive-drug-in-new-trials-ii05xlsc

“Alexion’s drug is the world’s most expensive,” Alnylam’s Chief Executive Officer John Maraganore said in an interview. “So we can think about that space with a pretty high ceiling.”